baber/WOPTO huggingface dataset:
Patent NZ-297629-A (NZ)
Title: Extrusion compositions having high drawdown and reduced neck-in comprising at least one ethylene/alpha-olefin interpolymer
Inventor: KALE LAWRENCE T
IPC: B29C48/09
Filed: 1995-11-13
Abstract: n ethylene polymer extrusion composition having high drawdown and substantially reduced neck-in, a process for making such a composition and a process of using such a composition to prepare extrusion coatings, extrusion profiles and extrusion cast films are disclosed.  The ethylene polymer extrusion composition is made of: 75-95 weight percent of at least one ethylene a-olefin interpolymer and 5-25 weight percent of at least one high pressure ethylene polymer and is characterized as having high melt strength and a broad, bimodal molecular weight distribution. In profiles, coatings or films, the composition can be used as sealant, adhesive or abuse resistance layers.
Patent NZ-331764-A (NZ)
Title: The use of N-(phosphonomethyl)glycine and derivatives thereof for the increase of yield and/or quality of crop plants that are resistant to glyphosate
Inventor: BRANTS IVO
IPC: A01N57/20
Filed: 1997-03-21
Abstract: The present invention concerns a new use of glyphosate or derivatives thereof e.g. monoisopropylammonium, ammonium or sodium salts or mixtures thereof, for the increase of yield and/or quality of crop plants that contain a glyphosate oxidoreductase enzyme gene, so making said crops tolerant to glyphosate.  Said crop plants selected from sugar beet, fodder beet, corn, oilseed rape and cotton.  The glyphosate is used in formulation with an adjuvant, preferably an amine, amine oxide, quaternary ammonium salts, alkylpolyglycoside, alkylglycoside, glucose-esters and sucrose-esters.
Patent NZ-331765-A (NZ)
Title: Cytochrome p450 transducing retroviral vectors contained in a capsule permeable to the cytochrome, pharmaceutical compositions thereof
Inventor: GUNZBURG WALTER H
IPC: A61K35/12
Filed: 1997-03-27
Abstract: A capsule encapsulating a cytochrome P450 producing cell comprising a porous membrane allowing a prodrug molecules to pass through into the capsule and after conversion of the prodrug into the active metabolite by cytochrome P450 allowing drug molecules to pass through out of the capsule is claimed.
Patent NZ-502551-A (NZ)
Title: Continuous production of lignocellulose composite panels with radio frequency prewarming of panels through precompression step
Inventor: MURPHY PAUL A
IPC: B27N3/24
Filed: 1997-02-06
Abstract: A binder is continuously applied to lignocellulose particles before the particles are continuously formed into a mat 4 of thickness 27 and pre-compressed in a pre-press 5.  Within the pre-press, at the location where the thickness of the mat 12 is the least, the mat is warmed by the application of a high-frequency, high-voltage field across electrodes 15, 16.  Leaving the pre-press the mat thickness springs back to thickness 13 and the mat is conveyed along a plane into press 6 and pressed into panels 7 with additional heating.
Patent NZ-505455-A (NZ)
Title: Methods for preserving fresh cut vegetables, using a preserving solution containing calcium ions and ascorbate ions or erythorbate ions and water
Inventor: CHEN CHAO
IPC: A23L35/00
Filed: 1999-01-08
Abstract: A method for preserving fresh-cut vegetables comprising the following steps: i) Providing a preservative solution comprising from 0.1 % to 10 % calcium ions by weight and from 0.1 % to 30 % ascorbate ions or erythorbate ions by weight, and water, and ii) Applying the vegetable preservative to the cut vegetable. The preservative solution is essentially free of a metal ion sequestrant, and is also essentially free of sodium and potassium ions. Also described is a method for preserving fresh-cut vegetables comprising the following steps: i) Providing a preservative solution comprising from 0.02 % to 15 % calcium ions by weight and from 0.1 % to 30 % ascorbate ions or erythorbate ions by weight, and water, and ii) Applying the vegetable preservative to the cut vegetable. The preservative solution is essentially free of citric acid, citrate ions, malic acid, malate ions, and a metal ion sequestrant.  Also described is a method for preserving fresh-cut vegetables comprising the following steps: i) Providing a preservative solution comprising from 0.1 % to 10 % calcium ions by weight and from 0.1 % to 30 % ascorbate ions or erythorbate ions by weight, and water, and ii) Applying the vegetable preservative to the cut vegetable. The preservative solution is essentially free a metal ion sequestrant. Also described is a cut vegetable, preserved by any of the above methods. Also described is a pizza containing a cut vegetable that has been preserved by any of the above methods.
Patent NZ-505947-A (NZ)
Title: The outsole of shoe, its manufacturing method, and its molding
Inventor: PARK YOUNG SOUL
IPC: A43D25/00
Filed: 1998-12-29
Abstract: An outsole of shoe, comprising a midsole (20) formed in a shooting moulding, in which throughout holes (22) pass through a front edge and a back edge in a sideways direction of the midsole, at least selected throughout holes having a protrusion (29) therein formed concurrently with the midsole.
Patent NZ-507467-A (NZ)
Title: Sunlight-ultraviolet-stable biocide compositions comprising an oxidising halogen compound and a benzenesulfonamide (or derivative thereof) as a stabiliser, and uses thereof in water treatment
Inventor: YANG SHUNONG
IPC: A01N59/00
Filed: 1999-04-12
Abstract: Described is a sunlight-ultraviolet-stable biocide composition for use in treating recreational and industrial water systems.  The composition comprises an oxidizing halogen compound and a stabilizer, wherein the stabilizer is either benzenesulfonamide or a derivative thereof.
Patent NZ-509182-A (NZ)
Title: Assigning functions to genes or DNA fragments, which have been sequenced but not accorded a particular function
Inventor: PLAETINCK GEERT
IPC: C12N15/82
Filed: 1999-07-02
Abstract: There is provided a method of identifying DNA responsible for conferring a particular phenotype in a cell. The method comprises a) constructing a cDNA or genomic library of the DNA of the cell in a suitable vector in an orientation relative to a promoter(s) capable of initiating transcription of the cDNA or DNA to double stranded (ds) RNA upon binding of an appropriate transcription factor to the promoter(s), b) introducing the library into one or more of the cells comprising the transcription factor, and c) identifying and isolating a particular phenotype of the cell comprising the library and identifying the DNA or cDNA fragment from the library responsible for conferring the phenotype. Using this technique it is also possible to assign function to a known DNA sequence by a) identifying a homologue(s) of the DNA sequence in a cell, b) isolating the relevant DNA homologue(s) or a fragment thereof from the cell, c) cloning the homologue or fragment thereof into an appropriate vector in an orientation relative to a suitable promoter(s) capable of initiating transcription of dsRNA from the DNA homologue or fragment upon binding of an appropriate transcription factor to the promoter(s) and d) introducing the vector into the cell from step a) comprising the transcription factor.
Patent NZ-513342-A (NZ)
Title: Digital video processing method and apparatus thereof
Inventor: SHIN HYUN-DOO
IPC: H04N7/50
Filed: 2000-02-03
Abstract: A digital video processing method and an apparatus thereof are provided. The method for processing digital images received in the form of compressed video streams comprising the step of determining a region intensity histogram (RIH) based on information on motion compensation of inter frames. The RIH information is obtained based on the motion compensation values of inter frames, and the RIH information is a good indicator of motion information of a video scene. Also, since the RIH information is quite a good indictor of intensity of the video scene, video streams having similar intensities can be effectively searched by searching for similar video scenes based on the RIH information obtained by the digital video processing method.
Patent NZ-513585-A (NZ)
Title: Calcined gypsum hydration enhancing additives
Inventor: WITTBOLD JAMES R
IPC: C04B28/14
Filed: 2000-10-13
Abstract: An additive for accelerating the setting reaction of gypsum products comprises a gypsum accelerator combined with a bisulfate salt. The gypsum accelerator is calcium sulfate dihydrate. The accelerator may be treated with a coating agent such as a sugar, a starch and/or boric acid. The additives are used in a process in which the bisulfate salt and a portion of the calcium sulfate hemihydrate feed are prewetted. The prewetted bisulfate salt and calcium sulfate hemihydrate feed is then combined in the main mixer with the gypsum accelerator, water and the remaining portion of the calcium sulfate hemihydrate feed to form a slurry. The slurry is formed into its desired shape and allowed to set.
Patent NZ-514922-A (NZ)
Title: Two piece hollow stem juvenile plant holding stake
Inventor: BAYLY PETER KINGSLEY
IPC: A01G17/04
Filed: 2001-10-18
Abstract: A stake (1) for stabilising a plant (2) comprising a foundation means (4) for stabilising the stake (1) in a fixed position near the plant (2), a foundation stem (5,6) extending from the foundation means (4), at least a portion of which is hollow, and holding means (7) connected to the foundation stem (5,6) for holding the plant or display object.
Patent NZ-515214-A (NZ)
Title: Encoding of microcarriers on or beneath the surface with multiple intensities for higher encoding rate
Inventor: SMEDT STEFAAN CORNELIS DE
IPC: G01N33/546
Filed: 2000-04-12
Abstract: Disclosed are encoded microcarriers, and more specifically microcarriers having codes written on them. A preferred method of encoding the microcarriers involves exposing microcarriers containing a bleachable substance to a high spatial resolution light source to bleach the codes on the microcarriers. The encoded microcarriers may be used, for example, as support materials in chemical and biological assays and syntheses. The figure shows a 45ìm FITC-labeled latex bead one hour after bleaching of the logo of Ghent University.
Patent NZ-516848-A (NZ)
Title: Retentate chromatography apparatus with applications in biology and medicine
Inventor: HUTCHENS T WILLIAM
IPC: G06F19/00
Filed: 1998-01-19
Abstract: Disclosed are probes for a mass spectrometer comprising a substrate, a surface and an adsorbent bound to the surface characterised in that a binding characteristic of the substrate varies in a gradient along one or more linear axes. Such binding characteristics include charge, hydrophobicity, hydrophilicity, valency etc.
Patent NZ-521346-A (NZ)
Title: Benzoamide piperidine containing compounds and related compounds
Inventor: ARNOLD ERIC PLATT
IPC: A61P27/02
Filed: 2001-04-06
Abstract: A compound of formula (I) is described. The compounds can be used in the manufacture of a medicament for treating or preventing mood disorders, dysthymic disorders, depressive neurosis and neurotic depression, melancholic depression, anorexia, weight loss, insomnia, early morning waking and psychomotor retardation, atypical depression (or reactive depression), including increased appetite, hypersomnia, psychomotor agitation or irritability, seasonal affective disorder and pediatric depression ; or bipolar disorders or manic depression; anxiety disorders, specific phobias, stress disorders; borderline personality disorder; schizophrenia, psychotic disorders, psychotic disorders, autistic disorder, delerium, dementia, and other cognitive or neurodegenerative disorders, such as Parkinson's disease, Huntington's disease, Alzheimer's disease, memory disorder and vascular dementia, Pick's disease, Creutzfeldt-Jakob disease; movement disorders such as akinesias, dyskinesias; extra-pyramidal movement disorders such as medication-induced movement disorders; substance related disorders arising from the use of alcohol, amphetamines, caffeine, cannabis, cocaine, hallucinogens, inhalants and aerosol propellants, nicotine, opioids, phenylglycidine derivatives, sedatives, hypnotics, and anxiolytics; epilepsy; Down's syndrome; pain and migraine; multiple sclerosis and amylolateral sclerosis, peripheral neuropathy, respiratory diseases such as chronic obstructive airways disease, bronchopneumonia, chronic bronchitis, cystic fibrosis, inflammatory diseases; HIV infections; allergies; ophthalmic diseases; cutaneous diseases; neoplasms, including breast tumours, gastric carcinomas, gastriclymphomas, neuroganglioblastomas and small cell carcinomas gastrointestinal disorders, adverse immunological reactions such as rejection of transplanted tissues; disorders of bladder function; fibrosing and collagen diseases; blood flow disorders caused by vasodilation and vasospastic diseases such as angina and Reynaud's disease; angiogenesis; cardiovascular disorders; eating disorders, such as anorexia nervosa and bulimia nervosa ; attention deficit hyperactivity disorder; chronic fatigue syndrome; sexual dysfunctions including premature ejaculation and male erectile dysfunction; premenstrual syndrome and premenstrual dysphoric disorder; fibromyalgia; and rheumatic diseases such as fibrositis. Also described are compounds of formula (II). In the compounds of formula (I) and (II) Q is C=S or C=O; Y is N and Z is CH or Y is CH and Z is N; W is a 1 or 2 carbon linking group. In formula (I) B is absent methylene or ethylene, G is NH(CH2)q, S(CH2)q or O(CH2)q wherein q is 0 or 1, with the proviso that when q is 0, G is NH, S or O and p is 0, 1 or 2.
Patent NZ-522280-A (NZ)
Title: Growth hormone secretagogues
Inventor: MARTINEZ JEAN
IPC: A61K31/405
Filed: 2001-06-13
Abstract: Disclosed are compounds of formula (I), wherein: one of R1 and R3 is a hydrogen and the other is a group of formula (II), R2 is hydrogen, alkyl, aryl, heterocyclic, cycloalkyl, (CH2)n-aryl, (CH2)n-heterocyclic, (CH2)n-cycloalkyl, methylsulfonyl, phenylsulfonyl, C(O)R8 or a group selected from formulae (III) to (VIII), R4 is hydrogen or alkyl, R5 is hydrogen, alkyl, (CH2)n-aryl, (CH2)n-heterocyclic, (CH2)n-cycloalkyl or amino, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases related to deficiency of growth hormone.
Patent NZ-526338-A (NZ)
Title: UV-or heat-triggered low oxygen packaging system employing an oxidizable polymer resin and a peroxide
Inventor: GALLAND M STEPHEN
IPC: B65D65/40
Filed: 2001-11-27
Abstract: A method of initiating oxygen scavenging in a packaging article comprising an oxygen scavenging polymer. The method comprises: - providing the packaging article comprising the oxygen scavenging polymer, where the packaging article comprises an interior surface and an exterior surface, - wetting the interior surface of the packaging article with a solution comprising a perioxide, to result in a packaging article with a wetted surface, and - exposing the wetted surface to an initiating factor, to initiate oxygen scavenging by the packaging article.
Patent NZ-528321-A (NZ)
Title: Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
Inventor: CASTILLO GERARDO M
IPC: A61P25/28
Filed: 2002-03-15
Abstract: Disclosed is the use of a catechin in the manufacture of medicaments for the treatment of an amyloid disease or a disease characterised by alpha-synuclein or NAC fibrillogenesis, such as Alzheimer's disease or Down's syndrome. Particular catechins include epicatechin, gallocatechin gallate, epigallocatechin gallate, epigallocatechin, and epicatechin gallate.
Patent NZ-528574-A (NZ)
Title: Liquid sprayers
Inventor: DUSHKIN ANDREY L
IPC: B05B7/00
Filed: 2002-03-21
Abstract: A liquid sprayer according to the first embodiment of the invention comprises a casing (1) having a flow-through channel composed of sequentially joined inlet portion (2) formed as a converging tube, a cylindrical portion (3) and an outlet portion (4) formed as a conical diffuser. A length of cylindrical portion (3) is not less than a radius thereof. A cone angle of the diffuser forming the outlet portion (4) of the flow-through channel is greater than a cone angle of the converging tube forming the inlet portion (2) of the same channel. According to the second embodiment of the invention, the converging tube forming the inlet portion of the flow-through channel is made conoid-shaped. Implementation of the invention allows steady-state fine-dispersed liquid flow to be generated at the minimal energy consumption.
Patent NZ-531142-A (NZ)
Title: Virtual credit card terminal and method of transaction
Inventor: LITSTER GREGORY JOHN
IPC: G06Q20/00
Filed: 2002-07-19
Abstract: A method of making a financial transaction over the internet includes election by the purchaser to pay for selected items from a merchant by credit card means using a virtual credit card terminal (VCT). The virtual credit card terminal includes credit card means reader, a digital processing device operatively associated with the credit card means reader and encoding transaction programs that allows opening of an interactive terminal window for processing of the transaction. The virtual credit card terminal is registered with VCT gateway. The purchaser is provided with a transaction number from the VCT gateway, merchant identification and amount to transact from the merchant. The merchant is registered with the VCT gateway. The purchaser enters details of credit card means into the virtual credit card terminal and forms a VCT transaction request. The VCT transaction request is sent to the VCT gateway. The VCT transaction request is processed by the VCT gateway and which forms a bank transaction request. The bank transaction request is sent from the VCT gateway to a bank which processes the bank transaction request and sends advice from the to the VCT gateway whether the transaction has been approved. The advice is sent from the VCT gateway to the merchant and the purchaser whether the transaction has been approved.
Patent NZ-532145-A (NZ)
Title: Process for producing fermented malt drink
Inventor: FUJINO SHUN ICHI
IPC: C12H1/02
Filed: 2002-09-25
Abstract: Disclosed is a process for producing fermented malt beverages with reduced content of purine compounds, wherein at least 90% of the total purine compounds in the fermented malt beverages are selectively adsorbed and removed with an activated charcoal with an average pore diameter of 1.8-2.4 nm in the production steps of the fermented malt beverages. Also disclosed are fermented malt beverages when produced by the process of the invention.
Patent NZ-536862-A (NZ)
Title: Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
Inventor: MURISON JAMES G
IPC: C07K14/715
Filed: 2003-05-27
Abstract: Disclosed is a method for modulating osteopontin expression in a population of cells, said method comprising the step of contacting said population of cells with a binding agent that specifically binds to FGFR5 polypeptide and is a modulator of FGFR5 polypeptide function.
Patent NZ-543805-A (NZ)
Title: 1-(Alkylaminoalkyl-pyrrolidinyl-/piperidinyl)-2,2-diphenylacetamide derivatives as muscarinic receptor antagonists
Inventor: MAMMEN MATHAI
IPC: C07D211/34
Filed: 2004-06-10
Abstract: Disclosed is a compound of formula (I), with substituents as defined in the specification, and pahrmaceutically acceptable slates thereof. Also disclosed is the use of the compound to treat a pulmonary disorder such as chronic obstructive pulmonary disease (COPD) or asthma. Also disclosed is a synthesis for the compound.
Patent NZ-545056-A (NZ)
Title: Manual powered generator and assemblies therewith, with handle spring tape and gear train
Inventor: POON WO HUEN
Filed: 2006-02-01
Abstract: Disclosed is a manually-powered electrical assembly. In one aspect, the manually-powered electrical assembly can be a light assembly that comprises a light source, an electrical generator, and a manual actuator assembly. The electrical generator is electrically connected to the light source and is operable to provide an electric current to the light source to operate the light source for providing light. The manual actuator assembly is arranged with the electrical generator for selectively manually operating the electrical generator. The manual actuator assembly includes an operator handle movable over a range of travel between a normal position and an operated position, a biasing mechanism for biasing the operator handle to the normal position, and a drive train connected to the operator handle and the electrical generator for rotating the rotor of the electrical generator. The assembly is operable to power other electrical devices such as a mobile phone or a fan.
Patent NZ-545894-A (NZ)
Title: Pre-treatment of DNA amplification solutions
Inventor: MORGAN HUGH WILLIAM
Filed: 2006-03-10
Abstract: Disclosed is a method of treating a solution prior to a DNA amplification reaction, including the steps of: (a) taking a base solution, which is void of template DNA for an amplification reaction, (b) mixing a binding agent which has at least one active form and at least one inactive form with the base solution, (c) subjecting the mixture from (b) to an external stimulus which converts the binding agent from an inactive to active form, causing the binding agent to bind to any contaminating DNA in the base solution so that the contaminating DNA is unreactive and is not co-amplified when the solution is subsequently utilised in a DNA amplification reaction during which the template DNA is added, (d) removing the external stimulus thereby converting the binding agent from an active to an inactive form.
Patent NZ-550283-A (NZ)
Title: Systems and methods for improving investing
Inventor: SCHLUNK OTMAR
IPC: G06Q40/00
Filed: 2005-04-22
Abstract: A method for simulating a business system that conducts a market transaction, performed by a provided computer system having a user is provided. The method includes: (a) determining, by the computer system, a price for an opportunity to participate in the market, which includes: (1) selecting, by the computer system, a set of mathematical factors from a number of sets, wherein the set of factors is associated with a predetermined price pattern; (2) selecting, by the computer system, a current factor from the selected set; and (3) determining, by the computer system, a price in accordance with the current factor, wherein determining the price in accordance with the current factor includes applying the current factor to an immediately prior market interval; (b) updating, by the computer system, a financial position of the user in response to a transaction; and (c) performing, by the computer system, the transaction in accordance with the price and an input from the user through a user interface of the computer system, where the input from the user corresponds in content to an input to the business system whereby the user develops skill in specifying market transactions to be conducted by reviewing changes in the user's financial position.